nateglinide 60 MG Oral Tablet
nateglinide
RxCUI: 314142
What the CMS Formulary Data Shows for nateglinide 60 MG Oral Tablet
Per the CMS 2026 Part D formulary file, nateglinide 60 MG Oral Tablet (RxNorm concept RXCUI 314142, generic name nateglinide) appears on 326 distinct formulary files spanning 5,041 Medicare Part D plan offerings - 99.5% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.4.
Real-world access to nateglinide 60 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 81.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 38,358 Part D beneficiaries filled nateglinide 60 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $14,130,522 and an average per-beneficiary annual cost of $368.39. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry nateglinide 60 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 326
- Plans covering
- 5,041
- Coverage rate
- 99.5%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 81.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 38,358
- Total spending
- $14,130,522
- Avg per beneficiary
- $368.39
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering nateglinide 60 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is nateglinide 60 MG Oral Tablet covered by Medicare Part D?
Yes, nateglinide 60 MG Oral Tablet is covered by 5,041 Medicare Part D plans (99.5% of all Part D formularies).
What tier is nateglinide 60 MG Oral Tablet on Medicare Part D plans?
nateglinide 60 MG Oral Tablet averages Tier 2.4 across Part D plans, ranging from Tier 1 to Tier 6.
Does nateglinide 60 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for nateglinide 60 MG Oral Tablet. Step therapy: 0%. Quantity limits: 81.9%.
How much does Medicare spend on nateglinide 60 MG Oral Tablet?
In 2023, total Medicare Part D spending on nateglinide 60 MG Oral Tablet was $14,130,522, covering 38,358 beneficiaries. The average spend per beneficiary was $368.39.
Read our methodology - how this data is sourced, computed, and verified.